Simplified High‐Performance Liquid Chromatography‐Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross‐Validation with Microparticle Enzyme Immunoassay

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Therapeutic Drug Monitoring

• Publication date

  1995-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00007691-199510000-00011PMID 8585114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.

  1994cited by this paper
• Comparison of Different Assays for the Quantitation of FK 506 Levels in Blood or Plasma

  1994cited by this paper
• Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).

  1994cited by this paper
• Adverse effects of FK 506 overdosage after liver transplantation.

  1993cited by this paper
• Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.

  1993cited by this paper
• Use of FK 506 in kidney transplantation.

  1993cited by this paper
• Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood.

  1992cited by this paper
• Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients.

  1992cited by this paper
• Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.

  1992cited by this paper
• In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism.

  1992cited by this paper
• High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients.

  1991cited by this paper
• THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVER

  1991cited by this paper
• Pharmacokinetics of FK 506 in transplant patients.

  1991cited by this paper
• Practical aspects of FK 506 analysis (Pittsburgh experience).

  1991cited by this paper
• FK 506 assay past and present--characteristics of FK 506 ELISA.

  1991cited by this paper
• Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.

  1991cited by this paper
• Monitoring FK 506 concentrations in plasma and whole blood.

  1991cited by this paper
• A combined HPLC-ELISA evaluation of FK 506 in transplant patients.

  1991cited by this paper
• A whole blood FK 506 assay for the IMx analyzer.

  1991cited by this paper
• Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.

  1991cited by this paper
• Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection.

  1990cited by this paper
• Assay of FK 506 in plasma.

  1990cited by this paper
• The effects of FK 506 on renal function after liver transplantation.

  1990cited by this paper
• Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

  1990cited by this paper

• Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations.

  2025cites this paper
• Tacrolimus: 20 years of use in adult kidney transplantation; what we should know about its nephrotoxicity.

  2020cites this paper
• Isotope-labeled versus analog internal standard in LC-MS/MS method for tacrolimus determination in human whole blood samples - A compensation of matrix effects.

  2019cites this paper
• Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.

  2018cites this paper
• Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition

  2017cites this paper
• Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.

  2016cites this paper
• Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients.

  2016cites this paper
• CYP3A and ABCB1 Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Tacrolimus and Its Metabolites (M-I and M-III)

  2013cites this paper
• Quantification of Tacrolimus and Three Demethylated Metabolites in Human Whole Blood Using LC–ESI–MS/MS

  2012influential citation
• Simple, Rapid and Sensitive Method for Determination of Nitrofurantoin in Human Plasma by using Liquid Chromatography/Tandem Mass Spectrometry

  2012cites this paper
• Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS.

  2011cites this paper
• Simple, Rapid and Sensitive Method for Determination of Tacrolimus in Human Blood by using Liquid Chromatography/Tandem Mass Spectrometry

  2010cites this paper
• Tratamiento inmunosupresor de la miastenia gravis con tacrolimus (FK506)

  2007cites this paper
• Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation

  2007cites this paper
• Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry.

  2006cites this paper
• Surface-activated chemical ionization and high-flow gradient chromatography to reduce matrix effect.

  2006cites this paper
• Immunosuppressants: Pharmacokinetics, methods of monitoring and role of high performance liquid chromatography/mass spectrometry

  2005cites this paper
• Determination of 13-O-demethyl tacrolimus in human liver microsomal incubates using liquid chromatography-mass spectrometric assay (LC-MS).

  2005cites this paper
• Therapeutic monitoring of immunosuppressant drugs. Where are we?

  2004cites this paper
• Tacrolimus ( FK 506 ) metabolite patterns in blood from liver and kidney transplant patients

  2004cites this paper
• Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry.

  2004cites this paper
• On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506).

  2004cites this paper
• Liquid chromatography/mass spectrometry for therapeutic drug monitoring of immunosuppressants

  2003cites this paper
• Pharmacokinetics of tacrolimus after multidose oral administration and efficacy in the prevention of allograft rejection in cats with renal transplants.

  2003cites this paper
• Comparison of an ELISA and an LC/MS/MS Method for Measuring Tacrolimus Concentrations and Making Dosage Decisions in Transplant Recipients

  2002cites this paper
• Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)

  2002cites this paper
• Comparative Clinical Pharmacokinetics of Tacrolimus in Paediatric and Adult Patients

  2001cites this paper
• Transformations in pharmaceutical research and development, driven by innovations in multidimensional mass spectrometry-based technologies

  2001cites this paper
• The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

  2001cites this paper
• Therapeutic Monitoring of Tacrolimus Concentrations in Blood: Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry

  2001cites this paper
• Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants.

  2000cites this paper
• Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography–Tandem Mass Spectrometry

  2000cites this paper
• LC/ESI-MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood.

  1999cites this paper
• Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).

  1999cites this paper
• Simultaneous on-line extraction and analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography-electrospray mass spectrometry.

  1999cites this paper
• Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).

  1998cites this paper
• Therapeutic drug monitoring of tacrolimus (FK506) using tandem mass spectrometry.

  1998cites this paper
• Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.

  1998cites this paper
• Liquid chromatography-mass spectrometry in forensic and clinical toxicology.

  1998cites this paper
• Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.

  1998cites this paper
• High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.

  1997cites this paper
• Pitfalls in monitoring tacrolimus (FK 506).

  1997cites this paper
• A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.

  1997cites this paper
• An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay.

  1997cites this paper
• Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies.

  1997cites this paper
• Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

  1997cites this paper
• Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

  1997cites this paper
• Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry

  1996cites this paper
• Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.

  1996cites this paper
• Clinical Pharmacokinetics of Tacrolimus

  1995cites this paper